Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 47 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 132 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  2. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  3. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  7. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  8. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  9. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  10. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  11. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  12. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  13. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  14. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  15. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  16. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  17. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  18. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  19. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  20. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  21. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  22. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  23. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  24. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  25. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  26. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  27. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  28. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  29. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  30. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  31. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  32. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  33. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  34. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  35. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  36. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  37. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  38. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  39. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  40. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  41. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  42. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  43. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  44. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  45. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  46. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  47. Poli V, et al. 2021. iScience. 24:103256. PubMed
  48. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  49. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  50. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  51. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  52. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  53. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  54. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  55. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  56. Chen S, et al. 2022. Cancer Discov. :. PubMed
  57. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  58. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  59. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  60. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  61. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  62. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  63. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  64. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  65. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  66. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  67. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  68. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  69. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  70. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  71. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  72. Li B, et al. 2022. iScience. 25:103772. PubMed
  73. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  74. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  75. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  76. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  77. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  78. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  79. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  80. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  81. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  82. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  83. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  84. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  85. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  86. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  87. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  88. Kasper M, et al. 2021. Elife. 10:. PubMed
  89. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  90. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  91. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  92. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  93. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  94. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  95. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  96. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  97. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  98. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  99. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  100. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  101. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  102. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  103. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  104. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  105. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  106. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  107. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  108. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  109. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  110. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  111. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  112. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  113. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  114. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  115. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  116. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  117. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  118. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  119. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  120. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  121. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  122. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  123. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  124. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  125. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  126. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  127. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  128. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  129. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  130. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  131. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  132. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  133. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  134. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  135. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  136. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  137. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  138. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  139. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  140. Gao H, et al. 2021. Cells. 10:. PubMed
  141. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  142. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  143. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  144. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  145. Köchl R, et al. 2020. Elife. 9:00. PubMed
  146. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  147. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  148. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  149. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  150. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  151. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  152. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  153. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  154. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  155. Dong S, et al. 2021. Nature. 591:117. PubMed
  156. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  157. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  158. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  159. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  160. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  161. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  162. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  163. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  164. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  165. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  166. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  167. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  168. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  169. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  170. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  171. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  172. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  173. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  174. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  175. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  176. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  177. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  178. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  179. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  180. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  181. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  182. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  183. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  184. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  185. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  186. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  187. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  188. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  189. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  190. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  191. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  192. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  193. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  194. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  195. Cho K, et al. 2021. iScience. 24:103117. PubMed
  196. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  197. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  198. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  199. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  200. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  201. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  202. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  203. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  204. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  205. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  206. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  207. Dong L, et al. 2022. Cells. 11:. PubMed
  208. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  209. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  210. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  211. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  212. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  213. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  214. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  215. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  216. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  217. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  218. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  219. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  220. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  221. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  222. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  223. Liu P, et al. 2022. iScience. 25:103867. PubMed
  224. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  225. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  226. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  227. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  228. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  229. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  230. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  231. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  232. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  233. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  234. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  235. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  236. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  237. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  238. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  239. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  240. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  241. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  242. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  243. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  244. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  245. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  246. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  247. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  248. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  249. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  250. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  251. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  252. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  253. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  254. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  255. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  256. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  257. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  258. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  259. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  260. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  261. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  262. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  263. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  264. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  265. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  266. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  267. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  268. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  269. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  270. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  271. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  272. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  273. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  274. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  275. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  276. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  277. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  278. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  279. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  280. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  281. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  282. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  283. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  284. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  285. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  286. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  287. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  288. Tang S, et al. 2022. Virol J. 19:32. PubMed
  289. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  290. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  291. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  292. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  293. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  294. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  295. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  296. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  297. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  298. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  299. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  300. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  301. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  302. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  303. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  304. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  305. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  306. Wang X, et al. 2022. Elife. 11:. PubMed
  307. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  308. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  309. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  310. Liu SS, et al. 2021. Immunity. :. PubMed
  311. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  312. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  313. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  314. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  315. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  316. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  317. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  318. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  319. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  320. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  321. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  322. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  323. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  324. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  325. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  326. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  327. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  328. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  329. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  330. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  331. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  332. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  333. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  334. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  335. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  336. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  337. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  338. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  339. Wang S, et al. 2022. Blood. 140:171. PubMed
  340. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  341. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  342. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  343. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  344. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  345. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  346. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  347. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  348. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  349. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  350. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  351. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  352. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account